Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma

Annals of Surgical Oncology

Volumn 5, Issue 4, 1998, Pages 322-328

  Heaton, Keith M ^a   Sussman, Jeffrey J ^a   Gershenwald, Jeffrey E ^a   Lee, Jeffrey E ^a   Reintgen, Douglas S ^b   Mansfield, Paul F ^a   Ross, Merrick I ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Margins; Melanoma; Recurrence; Surgery; Treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PROGNOSIS; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0031744752     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303495     Document Type: Article

References (28)

1. Breslow A, Macht SD. Optimal size of resection for thin cutaneous melanoma. Surg Gynecol Obstet 1977;145:691-2.
2. Balch CM, Murad TM, Soong S-J, Ingalls AL, Richards PC, Maddox W. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 1979;43:883-8.
3. Aitken DR, James AG, Carey LC. Local cutaneous recurrence after conservative excision of malignant melanoma. Arch Surg 1984; 119:643-6.
4. Cascinelli N, van der Esch EP, Breslow A, Morabito A, Bufalino R. W.H.O. Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanoma. Stage I melanoma of the skin: the problem of resection margins. Eur J Cancer Clin Oncol 1980;16:1079-85.
5. Cosimi AB, Sober AJ, Mihm MC, Fitzpatrick TB. Conservative surgical management of superficially invasive cutaneous melanoma. Cancer 1984;53:1256-9.
6. Elder DE, Guerry D, Heiberger RM, et al. Optimal resection margins for cutaneous malignant melanoma. Plast Reconstr Surg 1983;71:66-72.
7. Everall JD, Dowd PM. Diagnosis, prognosis, and treatment of melanoma. Lancet 1977;2:286-9.
8. Kelly KW, Sagebiel RW, Calderon W, Murillo L, Dakin RL, Blois MS. The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg 1984;200:759-61.
9. Taylor BA, Hughes LE. A policy of selective excision for primary cutaneous malignant melanoma. Eur J Surg Oncol 1985;11:7-13.
10. Veronesi U, Bajetta E, Cascinelli N, Clemente C, Rilke F. New trends in the treatment of malignant melanoma. Int Adv Surg Oncol 1978;1:113-56.
11. Day CL Jr, Mihm MC, Sober AJ, Fitzpatrick TB, Malt RA. Narrow margins for clinical stage I malignant melanoma, N Engl J Med 1982;306:479-82.
12. Veronesi U, Cascinelli N, Adamus J, Balch C, Bandeira D, et al. Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988;318: 1159-1162.
13. Veronesi U, Cascinelli N. Narrow excision (1-cm margin): a safe procedure for thin cutaneous melanoma. Arch Surg 1991;126:438-41.
14. Balch C, Urist M, Karakousis C, Smith T, Temple W. et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Ann Surg 1993;218:262-9.
15. Beahrs O, Henson D, Hutter R, Kennedy B, eds. Manual for Staging of Cancer, 4th ed. Philadelphia: JB Lippincott, 1993:155-160.
16. Balch C, Soong S-J, Shaw H, Urist M, McCarthy W. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch C, Houghton A, Milton G, Sober A, Soong S-J, eds. Cutaneous Melanoma. Philadelphia: JB Lippincott, 1992:165-91.
17. Parker S, Tong T, Bolden S, Wingo P. Cancer statistics 1997. CA Cancer J Clin 1997;47:5-27.
18. Ames F, Balch C, Reintgen D. Local recurrences and their management. In: Balch C, Houghton A, Milton G, Sober A, Soong S-J, eds. Cutaneous Melanoma. Philadelphia: JB Lippincott, 1992:287-94.
19. Karakousis C, Balch C, Urist M, Ross M, Smith T, Bartolucci A. Local recurrence in malignant melanoma: long-term results in the multiinstitutional randomized surgical trial. Ann Surg Oncol 1996; 3:446-52.
20. Lewis M, Hill J, Leopold J, Hughes L. Guidelines for management of malignant melanoma of the lower limb based on a study of long-term behaviour. Clin Oncol 1982;8:341-9.
21. McNeer G, Cantin J. Local failure in the treatment of melanoma. The Janeway Lecture. Am J Roentgenol 1967;99:791-5.
22. Roses D, Harris M, Rigel D, Carrey Z, Friedman R, Kopf A. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg 1983;198:65-9.
23. O'Rourke M, Altmann C. Melanoma recurrence after excision: is a wide margin justified? Ann Surg 1993;217:2-5.
24. Reintgen D, Vollmer R, Tso C, Seigler H. Prognosis for recurrent stage I malignant melanoma. Arch Surg 1987;122:1338-42.
25. Kirkwood J, Strawderman M, Ernstoff M, Smith T, Borden E, Blum R. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7-17.
26. Cole B, Gelber R, Kirkwood J, Goldhirsch A, Barylak E, Borden E. Quality of life adjusted survival analysis of interferon alpha-2b adjuvant treatment of high risk resected cutaneous melanoma: an ECOG study. J Clin Oncol 1996;14:2666-73.
27. Crowley N, Seigler H. The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma. Cancer 1990;6:2522-7.
28. Balch C, Soong S, Bartolucci A, et al. Efficacy of an elective lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255-66.